Denis Guyotat

5.8k total citations
124 papers, 3.4k citations indexed

About

Denis Guyotat is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Denis Guyotat has authored 124 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Hematology, 32 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Denis Guyotat's work include Acute Myeloid Leukemia Research (47 papers), Hematopoietic Stem Cell Transplantation (26 papers) and Acute Lymphoblastic Leukemia research (18 papers). Denis Guyotat is often cited by papers focused on Acute Myeloid Leukemia Research (47 papers), Hematopoietic Stem Cell Transplantation (26 papers) and Acute Lymphoblastic Leukemia research (18 papers). Denis Guyotat collaborates with scholars based in France, Romania and Switzerland. Denis Guyotat's co-authors include Lydia Campos, D Fière, E Archimbaud, D. Treille, Jacques Troncy, P Calmard-Oriol, T Tsuruo, Pascale Flandrin‐Gresta, Jérôme Cornillon and Xavier Thomas and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Denis Guyotat

118 papers receiving 3.3k citations

Peers

Countries citing papers authored by Denis Guyotat

Since Specialization

Citations

This map shows the geographic impact of Denis Guyotat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Guyotat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Guyotat more than expected).

Fields of papers citing papers by Denis Guyotat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis Guyotat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Guyotat. The network helps show where Denis Guyotat may publish in the future.

Co-authorship network of co-authors of Denis Guyotat

This figure shows the co-authorship network connecting the top 25 collaborators of Denis Guyotat. A scholar is included among the top collaborators of Denis Guyotat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Guyotat. Denis Guyotat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High-Dimensional Mass Cytometry Analysis of Embryonic Antigens and Their Signaling Pathways in Myeloid Cells from Bone Marrow Aspirates in AML Patients at Diagnosis 2023 ·Cancers ·(unknown), Estelle Devêvre, (unknown), Emmanuelle Tavernier, Denis Guyotat, (unknown)	0
2	Advanced Flow Cytometry Analysis Algorithms for Optimizing the Detection of “Different From Normal” Immunophenotypes in Acute Myeloid Blasts 2021 ·Frontiers in Cell and Developmental Biology ·(unknown), Richard Veyrat‐Masson, (unknown), (unknown), (unknown), Élisabeth Daguenet, Denis Guyotat, (unknown)	10
3	Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities 2021 ·Frontiers in Oncology ·(unknown), Richard Veyrat‐Masson, (unknown), (unknown), (unknown), Adrian P. Trifa, Ciprian Tomuleasa, (unknown), (unknown), Pascale Flandrin‐Gresta, (unknown), Denis Guyotat, (unknown)	4
4	Use of Complementary and Alternative Medicines among Cancer Patients: A Single-Center Study 2019 ·Oncology ·(unknown), Alexis Vallard, (unknown), (unknown), (unknown), Denis Guyotat, P. Fournel, Élisabeth Daguenet, Nicolas Magné, (unknown)	25
5	Prospective evaluation of systematic use of peripherally inserted central catheters (PICC lines) for the home care after allogeneic hematopoietic stem cells transplantation 2017 ·Supportive Care in Cancer ·Jérôme Cornillon, (unknown), Emmanuelle Tavernier, (unknown), (unknown), (unknown), Alexis Vallard, Karine Augeul-Meunier, (unknown), Denis Guyotat	13
6	An miRNA–DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia 2016 ·Clinical Cancer Research ·(unknown), Catherine Koering, (unknown), Delphine Maucort‐Boulch, Guillaume Robert, Patrick Auberger, Pascale Flandrin‐Gresta, Lionel Adès, Pierre Fenaux, Olivier Kosmider, Emmanuelle Tavernier, Jérôme Cornillon, Denis Guyotat, Lydia Campos, Franck Mortreux, Eric Wattel	29
7	Worsening of Respiratory Status during Neutropenia Recovery in Noncritically Ill Hematological Patients: Results of a Prospective Multicenter Study 2015 ·Respiration ·Marie Balsat, Aliénor Xhaard, Étienne Lengliné, Emmanuelle Tavernier, Jérôme Cornillon, Denis Guyotat, Michaël Darmon	6
8	HSP90 inhibition results in apoptosis of Philadelphia acute lymphoblastic leukaemia cells: an attractive prospect of new targeted agents 2012 ·Journal of Cancer Research and Clinical Oncology ·Emmanuelle Tavernier, Pascale Flandrin‐Gresta, (unknown), (unknown), Jérôme Cornillon, Karine Augeul-Meunier, Jean‐Louis Stephan, (unknown), (unknown), Denis Guyotat, Lydia Campos	4
9	Efficacy of environmental measures to decrease the risk of hospital-acquired aspergillosis in patients hospitalised in haematology wards 2006 ·Clinical Microbiology and Infection ·P. Berthelot, Pierre Loulergue, H. Rabérin, M. Turco, Christiane Mounier, R. Tran Manh Sung, (unknown), Bruno Pozzetto, Denis Guyotat	30
10	Effects of cryotherapy or chemotherapy on apoptosis in a non-small-cell lung cancer xenografted into SCID mice 2004 ·Cryobiology ·Valérie Forest, Michel Péoc’h, Lydia Campos, Denis Guyotat, Jean‐Michel Vergnon	45
11	Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patients 2003 ·Annals of Oncology ·Charles Dumontet, J. Jaubert, Catherine Sebban, Fadhela Bouafia, C Ardiet, Brigitte Tranchand, É. Berger, Catherine Lucas, Denis Guyotat, Bertrand Coiffier	7
12	Expression and activity of caspases 1 and 3 in myelodysplastic syndromes 2000 ·Leukemia ·Delphine Boudard, Olivier Sordet, C. Vasselon, (unknown), M. F. Bertheas, Damien Freyssenet, (unknown), S PISELLI, Denis Guyotat, Lydia Campos	36
13	Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation 1999 ·Bone Marrow Transplantation ·Mauricette Michallet, (unknown), Amine Belhabri, Lysiane Molina, Franck‐Emmanuel Nicolini, JD Tigaud, J.J. Sotto, Denis Guyotat, D Fière, E Archimbaud	16
14	Maintenance with low-dose cytarabine for acute myeloid leukemia in complete remission 1992 ·Annals of Hematology ·E Archimbaud, Bruno Anglaret, Xavier Thomas, J Jaubert, Catherine Sebban, Denis Guyotat, D Fière	6
15	CD 1‐reactive leukemic cells in bone marrow: Presence of Langerhans cell marker on leukemic monocytic cells 1992 ·European Journal Of Haematology ·L. Misery, Lydia Campos, Colette Dezutter‐Dambuyant, Denis Guyotat, D. Treille, Daniel Schmitt, J Thivolet	17
16	Phase II trial of plicamycin and hydroxyurea in acute myelogenous leukemia 1989 ·Cancer Chemotherapy and Pharmacology ·E Archimbaud, Jacques Troncy, Catherine Sebban, Denis Guyotat, Yves Devaux, (unknown), (unknown), (unknown), D Fière	9
17	Selective depletion of marrow-T cytotoxic lymphocytes (CD8) in the prevention of graft-versus-host disease after allogeneic bone-marrow transplantation 1988 ·Transplant International ·D Maraninchi, Claude Mawas, Denis Guyotat, Josy Reiffers, J P Vernant, N Gratecos, (unknown), G Novakovitch	15
18	Acute leukaemia with t(4;11) in patients previously exposed to carcinogens 1988 ·British Journal of Haematology ·E Archimbaud, C Charrin, Denis Guyotat, (unknown), O Gentilhomme, (unknown)	23
19	Acute Leukaemia following High-Dose Chemoradiotherapy with Bone Marrow Rescue for Ovarian Teratoma 1988 ·Acta Haematologica ·Denis Guyotat, B Coiffier, (unknown), E Archimbaud, D. Treille, (unknown), D Fière	5
20	Hypereosinophilic syndrome with multiple organ dysfunction treated by allogeneic bone marrow transplantation 1988 ·American Journal of Hematology ·E Archimbaud, Denis Guyotat, C. Guillaumé, Jean Godard, (unknown)	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact